Seeing Is Believing
Currently out of the existing stock ratings of Lawrence Biegelsen, 98 are a BUY (55.37%), 65 are a HOLD (36.72%), 14 are a SELL (7.91%).
Analyst Lawrence Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 72.41% that have a potential upside of 13.19% achieved within 174 days.
Lawrence Biegelsen’s has documented 740 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNDM, Tandem Diabetes Care at 07-Aug-2025.
Analyst best performing recommendations are on NARI (INARI MEDICAL ).
The best stock recommendation documented was for NARI (INARI MEDICAL ) at 3/10/2021. The price target of $125 was fulfilled within 1 day with a profit of $6.73 (5.69%) receiving and performance score of 56.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$85
$7.62 (9.85%)
$100
12 days ago
(28-Sep-2025)
4/5 (80%)
$10.89 (14.69%)
119
Hold
$77.53
$0.15 (0.19%)
$85.88
1 months 20 days ago
(20-Aug-2025)
2/2 (100%)
$-1.65 (-2.08%)
111
Buy
$110
$32.62 (42.16%)
$120
1 months 20 days ago
(20-Aug-2025)
8/11 (72.73%)
$30.82 (38.92%)
338
Buy
$95
$17.62 (22.77%)
$108
1 months 20 days ago
(20-Aug-2025)
7/11 (63.64%)
$15.82 (19.98%)
285
Buy
$107
$29.62 (38.28%)
$107
1 months 21 days ago
(19-Aug-2025)
15/27 (55.56%)
$25.96 (32.03%)
396
Which stock is Lawrence Biegelsen is most bullish on?
Which stock is Lawrence Biegelsen is most reserved on?
What Year was the first public recommendation made by Lawrence Biegelsen?